In the latest session, 2seventy bio Inc (NASDAQ: TSVT) closed at $4.86 down -2.51% from its previous closing price of $4.99. On the day, 932484 shares were traded.
Ratios:
For a deeper understanding of 2seventy bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.98 and its Current Ratio is at 3.98. In the meantime, Its Debt-to-Equity ratio is 1.01 whereas as Long-Term Debt/Eq ratio is at 0.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on January 31, 2024, Upgraded its rating to Outperform and sets its target price to $18 from $5 previously.
Leerink Partners Downgraded its Outperform to Market Perform on October 30, 2023, while the target price for the stock was maintained at $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 26 ’24 when Casdin Capital, LLC bought 40,000 shares for $5.10 per share. The transaction valued at 203,992 led to the insider holds 2,000,000 shares of the business.
Casdin Capital, LLC bought 330,000 shares of TSVT for $1,673,991 on Mar 25 ’24. The Director now owns 1,960,000 shares after completing the transaction at $5.07 per share. On Mar 22 ’24, another insider, Casdin Capital, LLC, who serves as the Director of the company, bought 147,377 shares for $5.12 each. As a result, the insider paid 754,069 and bolstered with 1,630,000 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.48 while its Price-to-Book (P/B) ratio in mrq is 0.96.
Stock Price History:
Over the past 52 weeks, TSVT has reached a high of $12.69, while it has fallen to a 52-week low of $1.53.
Shares Statistics:
A total of 50.63M shares are outstanding, with a floating share count of 47.64M. Insiders hold about 7.16% of the company’s shares, while institutions hold 93.43% stake in the company.
Earnings Estimates
There are 2seventy bio, Inc. different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $17.91, with high estimates of $12.45 and low estimates of $7.25.
